Organization
Genentech, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Genentech, Inc.
... GmbH (Germany)Bolder BioTechnology, Inc. (USA)F. Hoffmann-La Roche AG (Switzerland)Chugai Pharmaceutical Co. Ltd. (Japan)Genentech, Inc. (USA)FibroGen, Inc. (USA)Johnson & Johnson (USA)Janssen Biotech, Inc. (USA)Lonza Group (Switzerland)Merck ...
... pivotal trial of atezolizumab (TECENTRIQ), an anti-PDL1 antibody discovered and developed by Genentech, a member of the Roche Group, and cobimetinib (COTELLIC), an Exelixis-discovered MEK ...
... Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today ...
... Cancer Center of the University of Pennsylvania, Fred Hutchinson Cancer Research Center, Genentech (a member of the Roche Group), Huntsman Cancer Institute at the University ...
... hematologic malignancies evaluating venetoclax, a first-in-class BCL-2 inhibitor developed by AbbVie and Genentech, and ibrutinib, an inhibitor of Bruton's tyrosine kinase (BTK). Additionally, updated data ...
... the combination of BL-8040 and Merck's KEYTRUDA®; and a collaboration agreement with Genentech, a member of the Roche Group, to investigate the combination of BL-8040 ...
... 540w, https://si.wsj.net/public/resources/images/B3-AK291_WORKFA_M_20180514125906.jpg 860w" sizes="(max-width: 140px) 100px, (max-width: 540px) 500px, 860px" src="https://si.wsj.net/public/resources/images/B3-AK291_WORKFA_M_20180514125906.jpg" data-enlarge="https://si.wsj.net/public/resources/images/B3-AK291_WORKFA_M_20180514125906.jpg" alt="Genentech Genentech says a move to unassigned seating by some employee groups at ...
... ties, saying last June that the research collaboration with its biologics arm Genentech for work on the next-gen IDO/TDO (tryptophan 2,3-dioxygenase) inhibitors “continues.” No longer, ...
... Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced ...
Subscribe now for full coverage on Genentech, Inc.
Start My Free Trial